
---
title: '华润三九：拟29.02亿元购买昆药集团28%股份'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=7655'
author: 证券时报网
comments: false
date: Sun, 08 May 2022 16:45:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=7655'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ000999" style="color: #2f67d1;text-decoration: none;" code="000999" target="_blank">华润三九</a>(000999)5月8日晚间公告，公司拟以支付现金的方式向华立医药购买其所持有的<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600422" style="color: #2f67d1;text-decoration: none;" code="600422" target="_blank">昆药集团</a>27.56%股份，并向华立集团购买其所持有的<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600422" style="color: #2f67d1;text-decoration: none;" code="600422" target="_blank">昆药集团</a>0.44%股份。本次交易标的股份价格拟定为29.02亿元，对应<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600422" style="color: #2f67d1;text-decoration: none;" code="600422" target="_blank">昆药集团</a>每股转让价格为13.67元。交易完成后，公司将持有<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600422" style="color: #2f67d1;text-decoration: none;" code="600422" target="_blank">昆药集团</a>28%股份，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600422" style="color: #2f67d1;text-decoration: none;" code="600422" target="_blank">昆药集团</a>将成为<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SZ000999" style="color: #2f67d1;text-decoration: none;" code="000999" target="_blank">华润三九</a>的控股子公司。</p>

                  
</div>
            